Mouse Anti-FGL2 Recombinant Antibody (CBXF-2636) (CBMAB-F3056-CQ)

Shao, W., Huang, Y., Wang, L., Li, P., Jia, Y., & Zhang, J. (2023). Expression of fibrinogen-like protein 2 (Fgl2) on Toll-like receptor 9 (TLR9) expression in autoimmune myelitis. International Immunopharmacology, 114, 109539.

Zhang, S., Rao, G., Heimberger, A., & Li, S. (2022). Fibrinogen-like protein 2: its biological function across cell types and the potential to serve as an immunotherapy target for brain tumors. Cytokine & Growth Factor Reviews.

Pulkka, O. P., Viisanen, L., Tynninen, O., Laaksonen, M., Reichardt, P., Reichardt, A., ... & Joensuu, H. (2022). Fibrinogen‐like protein 2 in gastrointestinal stromal tumour. Journal of cellular and molecular medicine, 26(4), 1083-1094.

Liu, B. Q., Bao, Z. Y., Zhu, J. Y., & Liu, H. (2021). Fibrinogen‑like protein 2 promotes the accumulation of myeloid‑derived suppressor cells in the hepatocellular carcinoma tumor microenvironment. Oncology letters, 21(1), 1-1.

Robineau-Charette, P., Grynspan, D., Benton, S. J., Gaudet, J., Cox, B. J., Vanderhyden, B. C., & Bainbridge, S. A. (2020). Fibrinogen-like protein 2-associated transcriptional and histopathological features of immunological preeclampsia. Hypertension, 76(3), 910-921.

Hu, J., Wang, H., Li, X., Liu, Y., Mi, Y., Kong, H., ... & Wang, X. (2020). Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder. Theranostics, 10(21), 9702.

Wu, S., Li, M., Xu, F., Li, G. Q., Han, B. O., He, X. D., ... & Xu, G. L. (2020). Fibrinogen-like protein 2 deficiency aggravates renal fibrosis by facilitating macrophage polarization. Biomedicine & Pharmacotherapy, 130, 110468.

Latha, K., Yan, J., Yang, Y., Gressot, L. V., Kong, L. Y., Manyam, G., ... & Rao, G. (2019). The role of fibrinogen-like protein 2 on immunosuppression and malignant progression in glioma. JNCI: Journal of the National Cancer Institute, 111(3), 292-300.

Chen, T. J., Ji, M. X., Tao, Z. Q., Fu, Q. Y., Xiong, K., & Cheng, B. (2019). The relationship between serum fibrinogen-like protein 2 concentrations and 30-day mortality of patients with traumatic brain injury. Clinica Chimica Acta, 489, 53-57.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols